Maternal insulin therapy increases fetal endothelial progenitor cells during diabetic pregnancy.
Fadini
Gian Paolo
GP
Department of Clinical and Experimental Medicine, University of Padova Medical School, Padova, Italy. gianpaolo.fadini@unipd.it
Baesso
Ilenia
I
Agostini
Carlo
C
Cuccato
Emily
E
Nardelli
Giovanni Battista
GB
Lapolla
Annunziata
A
Avogaro
Angelo
A
D001724:Birth Weight / Q000187:drug effects; D016640:Diabetes, Gestational / Q000188:drug therapy*; D004730:Endothelium, Vascular / Q000187:drug effects / Q000196:embryology* / Q000502:physiology; D005260:Female; D005312:Fetal Blood / Q000166:cytology / Q000187:drug effects; D005333:Fetus / Q000187:drug effects / Q000502:physiology*; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D006943:Hyperglycemia / Q000517:prevention & control; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007231:Infant, Newborn; D007328:Insulin / Q000627:therapeutic use*; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000188:drug therapy*; D013234:Stem Cells / Q000166:cytology* / Q000187:drug effects
D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin